NYSEARCA:XBI - SPDR S&P Biotech ETF Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$89.21 +1.22 (+1.39 %)
(As of 03/26/2019 01:08 PM ET)
Previous Close$87.99
Today's Range$88.63 - $89.65
52-Week Range$64.38 - $101.55
Volume319,551 shs
Average Volume4.85 million shs
Market Capitalization$4.45 billion
P/E RatioN/A
Dividend Yield0.23%
BetaN/A
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

Receive XBI News and Ratings via Email

Sign-up to receive the latest news and ratings for XBI and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer SSgA
Fund NameSPDR S&P Biotech ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:XBI
Inception Date1/31/2006
Fund ManagerMichael Feehily, Karl Schneider, Raymond Donofrio
Phone+1-866-7872257

Fund Focus

Asset ClassEquity
BenchmarkS&P Biotechnology Select Industry TR USD
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$4.98 billion
Average Daily Volume$5.29 million
Discount/Premium-4.33%

ETF Expenses

Management Fee0.35%
Other Expenses0.00%
Total Expenses0.35%
Fee Waiver0.00%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorSSGA Funds Management, Inc.
AdvisorSSgA Funds Management, Inc.
CustodianState Street Bank and Trust Company
DistributorState Street Global Advisors Funds Distributors, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerVirtu Financial

Geographic Exposure of SPDR S&P Biotech ETF (NYSEARCA:XBI)
Currency Exposure of SPDR S&P Biotech ETF (NYSEARCA:XBI)
Sector Exposure of SPDR S&P Biotech ETF (NYSEARCA:XBI)
Industry Exposure of SPDR S&P Biotech ETF (NYSEARCA:XBI)

SPDR S&P Biotech ETF (NYSEARCA:XBI) Frequently Asked Questions

What is SPDR S&P Biotech ETF's stock symbol?

SPDR S&P Biotech ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XBI."

How often does SPDR S&P Biotech ETF pay dividends? What is the dividend yield for SPDR S&P Biotech ETF?

SPDR S&P Biotech ETF declared a quarterly dividend on Friday, December 21st. Investors of record on Monday, December 24th will be given a dividend of $0.012 per share on Thursday, December 27th. This represents a $0.05 dividend on an annualized basis and a yield of 0.05%. The ex-dividend date of this dividend is Friday, December 21st. View SPDR S&P Biotech ETF's Dividend History.

Has SPDR S&P Biotech ETF been receiving favorable news coverage?

Press coverage about XBI stock has been trending somewhat negative this week, InfoTrie Sentiment reports. The research firm scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. SPDR S&P Biotech ETF earned a news sentiment score of -1.4 on InfoTrie's scale. They also assigned news headlines about the exchange traded fund a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the next several days.

Are investors shorting SPDR S&P Biotech ETF?

SPDR S&P Biotech ETF saw a decline in short interest in the month of February. As of February 28th, there was short interest totalling 35,955,877 shares, a decline of 7.6% from the February 15th total of 38,923,643 shares. Based on an average daily trading volume, of 4,464,640 shares, the days-to-cover ratio is currently 8.1 days. View SPDR S&P Biotech ETF's Current Options Chain.

What other stocks do shareholders of SPDR S&P Biotech ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Biotech ETF investors own include NVIDIA (NVDA), Alibaba Group (BABA), Intel (INTC), Netflix (NFLX), Micron Technology (MU), iShares Nasdaq Biotechnology ETF (IBB), Invesco QQQ Trust (QQQ), Cisco Systems (CSCO), SPDR S&P 500 ETF Trust (SPY) and Walt Disney (DIS).

Who are SPDR S&P Biotech ETF's key executives?

SPDR S&P Biotech ETF's management team includes the folowing people:
  • James E. Ross, President, Trustee (Age 52)
  • Peter A. Ambrosini, Chief Compliance Officer (Age 69)
  • Michael P. Riley, Vice President (Age 44)
  • Gary L. French, Treasurer (Age 64)
  • John W. Clark, Assistant Treasurer (Age 46)
  • Matthew W. Flaherty, Assistant Treasurer (Age 42)
  • Chad C. Hallett, Assistant Treasurer of Street tracks series trust (Age 47)
  • Mary Moran Zeven, Secretary (Age 52)
  • Scott M. Zoltowski, Assistant Secretary (Age 44)
  • Dave Kelly, Independent Trustee

Who are SPDR S&P Biotech ETF's major shareholders?

SPDR S&P Biotech ETF's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Duality Advisers LP (1.50%), CI Investments Inc. (0.87%), Main Management ETF Advisors LLC (0.57%), Thrivent Financial for Lutherans (0.49%), LPL Financial LLC (0.48%) and Harel Insurance Investments & Financial Services Ltd. (0.46%).

Which institutional investors are selling SPDR S&P Biotech ETF stock?

XBI stock was sold by a variety of institutional investors in the last quarter, including Rafferty Asset Management LLC, SG Americas Securities LLC, CI Investments Inc., LPL Financial LLC, Nuveen Asset Management LLC, Howard Capital Management, Smart Portfolios LLC and TRUE Private Wealth Advisors.

Which institutional investors are buying SPDR S&P Biotech ETF stock?

XBI stock was bought by a variety of institutional investors in the last quarter, including Duality Advisers LP, American Financial Advisors LLC, Cumberland Advisors Inc., American Century Companies Inc., Highbridge Capital Management LLC, Sivik Global Healthcare LLC, Rehmann Capital Advisory Group and Tocqueville Asset Management L.P..

How do I buy shares of SPDR S&P Biotech ETF?

Shares of XBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is SPDR S&P Biotech ETF's stock price today?

One share of XBI stock can currently be purchased for approximately $89.43.

How big of a company is SPDR S&P Biotech ETF?

SPDR S&P Biotech ETF has a market capitalization of $4.46 billion.

What is SPDR S&P Biotech ETF's official website?

The official website for SPDR S&P Biotech ETF is https://www.spdrs.com/.

How can I contact SPDR S&P Biotech ETF?

SPDR S&P Biotech ETF's mailing address is One Lincoln Street, Boston, 02111, United States. The exchange traded fund can be reached via phone at +1-866-7872257.


MarketBeat Community Rating for SPDR S&P Biotech ETF (NYSEARCA XBI)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  63 (Vote Outperform)
Underperform Votes:  83 (Vote Underperform)
Total Votes:  146
MarketBeat's community ratings are surveys of what our community members think about SPDR S&P Biotech ETF and other stocks. Vote "Outperform" if you believe XBI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XBI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/26/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel